Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118840712 | 11884071 | 2 | F | 20151116 | 20160906 | 20160102 | 20160906 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-091986 | BRISTOL MYERS SQUIBB | 47.59 | YR | F | Y | 0.00000 | 20160906 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118840712 | 11884071 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 30 MG, QD (2 15MG TABLETS PER DAY) | 21436 | 30 | MG | TABLET | QD | ||||||
| 118840712 | 11884071 | 2 | SS | NOZINAN /00038601/ | LEVOMEPROMAZINE | 1 | Oral | 150 MG, QD | 0 | 150 | MG | TABLET | QD | ||||||
| 118840712 | 11884071 | 3 | SS | ZYPREXA | OLANZAPINE | 1 | Oral | 15 MG, QD | 0 | 15 | MG | CAPSULE | QD | ||||||
| 118840712 | 11884071 | 4 | SS | EPITOMAX | TOPIRAMATE | 1 | Oral | 50 MG, QD | 0 | 50 | MG | TABLET | QD | ||||||
| 118840712 | 11884071 | 5 | SS | PAROXETINE ARROW | PAROXETINE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 118840712 | 11884071 | 6 | C | PARKINANE LP | TRIHEXYPHENIDYL HYDROCHLORIDE | 1 | Oral | 5 MG, QD | 0 | 5 | MG | CAPSULE | QD | ||||||
| 118840712 | 11884071 | 7 | C | SULFARLEM | ANETHOLTRITHION | 1 | Oral | 125 MG, QD | U | 0 | 125 | MG | TABLET | QD | |||||
| 118840712 | 11884071 | 8 | C | STILNOX | ZOLPIDEM TARTRATE | 1 | Oral | 5 MG, QD | 0 | 5 | MG | TABLET | QD | ||||||
| 118840712 | 11884071 | 9 | C | CERIS | TROSPIUM CHLORIDE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | TABLET | QD | ||||||
| 118840712 | 11884071 | 10 | C | TOVIAZ | FESOTERODINE FUMARATE | 1 | Oral | 4 MG, QD | U | 0 | 4 | MG | TABLET | QD | |||||
| 118840712 | 11884071 | 11 | C | DOLIPRANE | ACETAMINOPHEN | 1 | Oral | 3 G, QD | 0 | 3 | G | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118840712 | 11884071 | 1 | Mental disorder |
| 118840712 | 11884071 | 2 | Mental disorder |
| 118840712 | 11884071 | 3 | Mental disorder |
| 118840712 | 11884071 | 4 | Mental disorder |
| 118840712 | 11884071 | 5 | Mental disorder |
| 118840712 | 11884071 | 6 | Product used for unknown indication |
| 118840712 | 11884071 | 7 | Product used for unknown indication |
| 118840712 | 11884071 | 8 | Insomnia |
| 118840712 | 11884071 | 9 | Urinary incontinence |
| 118840712 | 11884071 | 10 | Urinary incontinence |
| 118840712 | 11884071 | 11 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118840712 | 11884071 | HO |
| 118840712 | 11884071 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118840712 | 11884071 | Product use issue | |
| 118840712 | 11884071 | Pulmonary embolism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |